Ethylene

Ethylene

SCHEMBL6989724

C=C.CCOC(C)OCC.O=C1CNS(=O)(=O)c2ccccc21

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.36
CA9 Q16790 4/20 0.36
CA2 P00918 2/20 0.36
KDM4E B2RXH2 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 2/20 0.36
USP2 O75604 1/20 0.36
CA1 P00915 1/20 0.36
BCHE P06276 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
CTDSP1 Q9GZU7 3/20 0.35
TDP1 Q9NUW8 2/20 0.33
PKM P14618 1/20 0.33
BRD4 O60885 1/20 0.31
ALPI P09923 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopropane SCHEMBL6998820 0.95 KDM4E (0.36) CA12CA9CA2KDM4EKMT2A
Ethylene SCHEMBL6995383 0.85 CHEK1 (0.35) CA12CA9CA2KDM4EKMT2A
Ethylene SCHEMBL8644508 0.83 KDM4E (0.48) CA12CA9CA2KDM4EKMT2A
Ethylene SCHEMBL6995835 0.83 CHEK1 (0.41) CA12CA9CA2KDM4ELMNA
Ethylene SCHEMBL6988767 0.82 L3MBTL1 (0.39) CA12CA9CA2KDM4ECA1
Ethylene SCHEMBL6994474 0.82 GRIA2 (0.38) CA12CA9CA2KDM4ECA1
Ethylene SCHEMBL7110313 0.81 RET (0.42) CA12CA9CA2CA1CA4
Ethylene SCHEMBL6993460 0.81 KCNA5 (0.38) KDM4EKMT2AUSP2TDP1ALPI
SCHEMBL6997121 0.80 KDM4E (0.52) CA12CA9CA2KDM4EKMT2A
Ethylene SCHEMBL6999949 0.72 TDP1 (0.52) CA12CA9CA2KMT2ACTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
EP-0686632-B1 BENZOTHIAZINE DERIVATIVE DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-08-06 EP disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
US-5874429-A ANTIISCHEMIC AGENTS; CEREBROVASCULAR DISORDERS; CIRCULATORY IDSORDERS SUNTORY LIMITED (JP) 1999-02-23 US disclosed
EP-0686632-A1 BENZOTHIAZINE DERIVATIVE SUNTORY LIMITED (JP) 1995-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 CA12 4559/4885CA9 4680/4885CA2 2081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.